Management of necrotizing cellulitis and fasciitis. | Canada Hyperbarics Skip to main content
RCT Annales de dermatologie et de venereologie 2001

Management of necrotizing cellulitis and fasciitis.

Derancourt C — Annales de dermatologie et de venereologie, 2001

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers conducted a literature review to outline a comprehensive treatment protocol for necrotizing cellulitis and fasciitis.

What They Found

The review found that immediate or early surgical debridement of all necrotic tissue and extensive fasciotomy are crucial, followed by surgical reexamination of the infected area. An initial antibiotic therapy targeting aerobic Gram-positive and Gram-negative organisms and anaerobes, such as amoxicillin-clavulanic acid or vancomycin-metronidazole, is recommended. Additionally, adequate nutritional support, infusion, and resuscitation are essential, while hyperbaric oxygen therapy may be considered as an associated treatment.

Canadian Relevance

This study has no direct Canadian connection as it was not conducted in Canada, but the medical principles for managing necrotizing fasciitis are globally applicable.

Study Limitations

A key limitation is the lack of controlled studies or randomised controlled trials to definitively establish the efficacy of various components of the proposed treatment protocol, particularly hyperbaric oxygen therapy.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type RCT
Category Infection
Source Pubmed
PubMed ID 11319377
Year Published 2001
Journal Annales de dermatologie et de venereologie
MeSH Terms Anti-Bacterial Agents; Cellulitis; Fasciitis, Necrotizing; Humans; Hyperbaric Oxygenation; Radiography

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology